TNNI3 and COVID-19: Our meta-analysis demonstrated that 20.0% (95% CI 16.1–23.8% with substantial heterogeneity (I2 = 94.9%)) of hospitalized COVID-19 patients had a myocardial injury manifested mainly by elevated cardiac troponin I levels (Online Supplementary Data).